COVID-19-neutralizing antibodies predict disease severity and survival

Mostrar otras versiones (1)

Coronavirus disease 2019 (COVID-19) exhibits variable symptom severity ranging from asymptomatic to life-threatening, yet the relationship between severity and the humoral immune response is poorly understood. We examined antibody responses in 113 COVID-19 patients and found that severe cases result...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Beltran, Wilfredo F., Lam, Evan C., Astudillo, Michael G., Yang, Diane, Miller, Tyler E., Feldman, Jared, Hauser, Blake M., Caradonna, Timothy M., Clayton, Kiera L., Nitido, Adam D., Murali, Mandakolathur R., Alter, Galit, Charles, Richelle C., Dighe, Anand, Branda, John A., Lennerz, Jochen K., Lingwood, Daniel, Schmidt, Aaron G., Iafrate, A. John, Balazs, Alejandro B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837114/
https://www.ncbi.nlm.nih.gov/pubmed/33412089
http://dx.doi.org/10.1016/j.cell.2020.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837114/
https://www.ncbi.nlm.nih.gov/pubmed/33412089
http://dx.doi.org/10.1016/j.cell.2020.12.015

Ejemplares similares